<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Tegretol preparations; Carbamazepine: epilepsy" /><meta name="IX" content="Tegretol preparations; Carbamazepine: epilepsy" /><title>Tegretol® Prolonged Release: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP2915-tegretol-prolonged-release.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP2915-tegretol-prolonged-release.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP2915-tegretol-prolonged-release.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP2092-central-nervous-system.htm">4 Central nervous system</a> &gt; <a href="PHP2897-antiepileptic-drugs.htm">4.8 Antiepileptic drugs</a> &gt; <a href="PHP2898-control-of-the-epilepsies.htm">4.8.1 Control of the epilepsies</a> &gt; <a href="PHP2908-carbamazepine-and-related-antiepileptics.htm">Carbamazepine and related antiepileptics</a> &gt; <a href="PHP2909-carbamazepine.htm">CARBAMAZEPINE</a> &gt; <a href="PHP2913-modified-release.htm">Modified release</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP2908-carbamazepine-and-related-antiepileptics.htm" title="Previous: Carbamazepine and related antiepileptics">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP2916-eslicarbazepine-acetate.htm" title="Next: ESLICARBAZEPINE ACETATE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382237.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carbamazepine</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Anticonvulsants 28:12 &gt; Anticonvulsants, Miscellaneous 28:12.92</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/6605-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Carbamazepine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: C &gt; Interactions of Carbamazepine</p></div></li></ul><ul><li><h3>British National Formulary (14)</h3></li><li><a href="PHP120-miscellaneous-conditions.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Miscellaneous conditions</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Guidance on prescribing &gt; Prescribing in palliative care</p></div></li><li><a href="PHP180-active-elimination-techniques.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Active elimination techniques</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Emergency treatment of poisoning &gt; Removal and elimination</p></div></li><li><a href="PHP2329-carbamazepine.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carbamazepine</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.2 Drugs used in psychoses and related disorders &gt; 4.2.3 Antimanic drugs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (14)</a></li></ul><ul><li><h3>BNF for Children (12)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP10973-pain.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pain</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; General guidance &gt; Prescribing in palliative care</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP11010-removal-and-elimination.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Removal and elimination</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; Emergency treatment of poisoning</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12183-carbamazepine.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carbamazepine</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.2 Drugs used in psychoses and related disorders &gt; 4.2.3 Antimanic drugs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (12)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/c-d1e193704.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carbamazepine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; C</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c475-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxcarbazepine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; O</p></div></li></ul><ul><li><h3>Dietary Supplements</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c79.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Psyllium</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0003s0049.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carbamazepine</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; C</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/A04-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Acetylcysteine</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; A</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/6605-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carbamazepine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiepileptics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/19623-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Oxcarbazepine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiepileptics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/01781.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carbamazepine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; C &gt; CA</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c5-sec1-003.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">The Periodic Table and Families of Elements</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 2: Pharmaceutical Chemistry &gt; 5 Inorganic Pharmaceutical Chemistry</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c22-sec1-002.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mathematics of Dissolution</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 3: Pharmaceutical Analysis And Quality Control &gt; 22 Dissolution</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c26-sec1-001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Molecular structure and properties</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 4: Pharmaceutics &gt; 26 Molecular Structure, Properties, and States of Matter</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22%22carbamazepine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D114.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Carbamazepine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; C</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c67.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Carbamazepine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; C</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>CARBAMAZEPINE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int277-carbamazepine.htm">Carbamazepine</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">focal and secondary generalised tonic-clonic seizures, primary generalised tonic-clonic seizures; trigeminal neuralgia; prophylaxis of bipolar disorder unresponsive to lithium; adjunct in acute alcohol withdrawal [unlicensed] (<a title="BNF:sub-section: Alcohol dependence" href="PHP3177-alcohol-dependence.htm">section 4.10.1</a>); diabetic neuropathy [unlicensed] (<a title="BNF:topic: Diabetic neuropathy" href="PHP4234-diabetic-neuropathy.htm">section 6.1.5</a>)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">cardiac disease (see also Contra-indications); skin reactions (see also Blood, Hepatic, or Skin Disorders, below and under Side-effects); test for HLA-B*1502 allele in individuals of Han Chinese or Thai origin (avoid unless no alternative—risk of Stevens-Johnson syndrome in presence of HLA-B*1502 allele); history of haematological reactions to other drugs; manufacturer recommends blood counts and hepatic and renal function tests (but evidence of practical value uncertain); may exacerbate absence and myoclonic seizures; consider vitamin D supplementation in patients who are immobilised for long periods or who have inadequate sun exposure or dietary intake of calcium; susceptibility to angle-closure glaucoma; cross-sensitivity reported with oxcarbazepine and with phenytoin (see also <a title="BNF:target-block: antiepileptic hypersensitivity syndrome" href="PHP2898-control-of-the-epilepsies.htm#PHP2901">Antiepileptic Hypersensitivity Syndrome</a>); avoid abrupt withdrawal; <strong>interactions:</strong> see <a title="target-block: Interactions in epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2899">Interactions</a> in section 4.8.1 and Appendix 1 (carbamazepine)</p></div> <div id="PHP2910" class="cG"><div class="cE"><h3 class="cT">Blood, hepatic, or skin disorders</h3> <p class="cT">Patients or their carers should be told how to recognise signs of blood, liver, or skin disorders, and advised to seek immediate medical attention if symptoms such as fever, rash, mouth ulcers, bruising, or bleeding develop. Carbamazepine should be withdrawn immediately in cases of aggravated liver dysfunction or acute liver disease. Leucopenia that is severe, progressive, or associated with clinical symptoms requires withdrawal (if necessary under cover of a suitable alternative).</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">AV conduction abnormalities (unless paced); history of bone-marrow depression, acute porphyria (<a title=" Acute porphyrias" href="PHP6363-acute-porphyrias.htm">section 9.8.2</a>)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">metabolism impaired in advanced liver disease; see also Blood, Hepatic, or Skin Disorders, above</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">use with caution</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">see <a title="BNF:target-block: Pregnancy and breast-feeding in epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2903">Pregnancy</a>; monitor plasma-carbamazepine concentration</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">see <a title="BNF:target-block: breast-feeding control of epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2904">Breast-feeding</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see <a title="BNF:monograph-family: Carbamazepine and related antiepileptics" href="PHP2908-carbamazepine-and-related-antiepileptics.htm">notes above</a>; also dry mouth, nausea, vomiting, oedema, ataxia, dizziness, drowsiness, fatigue, headache, hyponatraemia (leading in rare cases to water intoxication), blood disorders (including eosinophilia, leucopenia, thrombocytopenia, haemolytic anaemia, and aplastic anaemia), dermatitis, urticaria; <em>less commonly</em> diarrhoea, constipation, involuntary movements (including nystagmus), visual disturbances; <em>rarely</em> abdominal pain, anorexia, hepatitis, jaundice, vanishing bile duct syndrome, cardiac conduction disorders, hypertension, hypotension, peripheral neuropathy, dysarthria, aggression, agitation, confusion, depression, hallucinations, restlessness, paraesthesia, lymph node enlargement, muscle weakness, systemic lupus erythematosus, delayed multi-organ hypersensitivity disorder (see also <a title="BNF:target-block: antiepileptic hypersensitivity syndrome" href="PHP2898-control-of-the-epilepsies.htm#PHP2901">Antiepileptic Hypersensitivity Syndrome</a>); <em>very rarely</em> pancreatitis, stomatitis, hepatic failure, taste disturbance, exacerbation of coronary artery disease, AV block with syncope, circulatory collapse, hypercholesterolaemia, thrombophlebitis, thromboembolism, pulmonary hypersensitivity (with dyspnoea, pneumonitis, or pneumonia), psychosis, neuroleptic malignant syndrome, osteomalacia (see Cautions), osteoporosis, galactorrhoea, gynaecomastia, impaired male fertility, interstitial nephritis, renal failure, sexual dysfunction, urinary frequency, urinary retention, arthralgia, muscle pain, muscle spasm, conjunctivitis, angle-closure glaucoma, hearing disorders, acne, alterations in skin pigmentation, alopecia, hirsutism, sweating, photosensitivity, purpura, Stevens-Johnson syndrome, toxic epidermal necrolysis, aseptic meningitis; suicidal ideation</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Different preparations may vary in bioavailability; to avoid reduced effect or excessive side-effects, it may be prudent to avoid changing the formulation</p></div></div><ul>  <li><p>Epilepsy, <span class="cK">by mouth</span>, initially 100–200 mg 1–2 times daily, increased slowly (see <a title="BNF:monograph-family: Carbamazepine and related antiepileptics" href="PHP2908-carbamazepine-and-related-antiepileptics.htm">notes above</a>) to usual dose of 0.8–1.2 g daily in divided doses; in some cases 1.6–2 g daily in divided doses may be needed; <span class="cP">elderly</span> reduce initial dose; <span class="cP">child</span> daily in divided doses, up to 1 year 100–200 mg, 1–5 years 200–400 mg, 5–10 years 400–600 mg, 10–15 years 0.6–1 g</p> <p><span class="cK">By rectum</span>, for short-term use (max. 7 days) when oral therapy temporarily not possible; 125-mg suppository approx. equivalent to 100-mg tablet, but final adjustment should always depend on clinical response (plasma concentration monitoring recommended); max. 1 g daily in 4 divided doses</p> </li> <li><p>Trigeminal neuralgia, <span class="cK">by mouth</span>, initially 100 mg 1–2 times daily (but some patients may require higher initial dose), increased gradually according to response; usual dose 200 mg 3–4 times daily, up to 1.6 g daily in some patients</p> </li> <li><p>Prophylaxis of bipolar disorder unresponsive to lithium (see also <a title=" Antimanic drugs" href="PHP2324-antimanic-drugs.htm">section 4.2.3</a>), <span class="cK">by mouth</span>, initially 400 mg daily in divided doses increased until symptoms controlled; usual range 400–600 mg daily; max. 1.6 g daily</p> </li> <li><p>Treatment of alcohol withdrawal [unlicensed indication], <span class="cK">by mouth</span>, initially 800 mg daily in divided doses, reduced gradually over 5 days to 200 mg daily; usual treatment duration 7–10 days</p> </li> <li><p>Diabetic neuropathy [unlicensed indication], <span class="cK">by mouth</span>, initially 100 mg 1–2 times daily, increased gradually according to response; usual dose 200 mg 3–4 times daily, up to 1.6 g daily in some patients</p> </li>  </ul><div class="cF"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Plasma concentration for optimum response 4–12 mg/litre (20–50 micromol/litre)</p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP2911-carbamazepine-non-proprietary.htm#PHP2911-carbamazepine-non-proprietary" title="Carbamazepine">Carbamazepine</a></li><li><a href="PHP2912-tegretol.htm#PHP2912-tegretol" title="Tegretol®">Tegretol®</a></li></ul><div id="PHP2913-modified-release" style="margin: 0 0 0 20px;"><h1 class="title">Modified release</h1><ul class="jT"><li><a href="PHP2914-carbagen-sr.htm#PHP2914-carbagen-sr" title="Carbagen® SR ">Carbagen® SR </a></li></ul><div id="PHP2915-tegretol-prolonged-release" style="margin: 0 0 0 20px;"><h1 class="title">Tegretol® Prolonged Release <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10261">Novartis</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, m/r, scored, carbamazepine 200 mg (beige-orange), net price 56-tab pack = £5.20; 400 mg (brown-orange), 56-tab pack = £10.24. Label: 3, 8, 25, counselling, blood, hepatic or skin disorder symptoms (see <a title="target-block: blood, hepatic, skin disorders" href="PHP2909-carbamazepine.htm#PHP2910">above</a>), driving (see <a title="target-block: Driving and epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2902">notes above</a>)</p><p class="cR"><strong>Dose </strong>epilepsy, <span class="cP">adult</span> and <span class="cP">child</span> over 5 years, as above; trigeminal neuralgia, as above; bipolar disorder, as above; total daily dose given in 2 divided doses</p></div></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP2908-carbamazepine-and-related-antiepileptics.htm">Previous: Carbamazepine and related antiepileptics</a> | <a class="top" href="PHP2915-tegretol-prolonged-release.htm#">Top</a> | <a accesskey="]" href="PHP2916-eslicarbazepine-acetate.htm">Next: ESLICARBAZEPINE ACETATE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>